Clear Labelling Of Industrial & Medical Oxygen Must, PMO Tells Health Ministry

New Delhi:  The Prime Minister’s Office (PMO) has written to the health ministry to take necessary action regarding the labelling of oxygen cylinders to differentiate between industrial and medical oxygen after lawmaker Ajeet Madhavrao Gopchade raised the need to do so in the interest of patients.

“I brought this to the notice of the PMO. As a doctor, I understand it is a critical issue and needs attention. To protect patients, even the World Health Organization has released guidelines on the quality of medical oxygen,” Gopchade told ET.

“Throughout the Covid pandemic, it was noted that a significant number of patients who needed external oxygen support acquired a fungal infection. Unfortunately, many individuals lost their eyesight as a result. There seems to be a lack of focus from the state and central government on guaranteeing the quality of medical oxygen. There is a shortage of clear labelling on oxygen cylinders to differentiate between industrial and medical oxygen,” the lawmaker said in his letter to the PMO.

He urged the PMO to instruct the relevant authorities to issue advisory to state governments directing them to ensure the quality of medical oxygen and conduct mandatory inspections of medical oxygen production facilities.

Taking cognizance of the issue, the PMO has written to the health ministry directing it “to take action as deemed appropriate”.

In India, the Ministry of Health and Family Welfare (MoHFW) and the Department for Promotion of Industry and Internal Trade (DPIIT) are responsible for managing the supply of medical oxygen in India. While the health ministry develops guidelines for setting up oxygen plants, DPIIT manages the supply of medical oxygen, including drugs and equipment.

Different industries, including health systems, use oxygen on a regular basis. According to the WHO, medical-use oxygen is very different from industrial oxygen in purity and quality. “Thus, industrial and medical use (oxygen) are not interchangeable,” says the WHO document.

Related Posts

Delhi HC allows Zydus to sell biosimilar of blockbuster anti-cancer drug Nivolumab

‘Where the product in question is a life-saving drug, the Court has to err in favour of public interest’, said the bench The Delhi High Court on Monday cleared the…

DoP may exempt 11 more drugs from public procurement rules

New Delhi: The Department of Pharmaceuticals (DoP) has proposed to add 11 more drugs including insulin and monoclonal antibodies to the list of 84 drug formulations it has mentioned in…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Delhi HC allows Zydus to sell biosimilar of blockbuster anti-cancer drug Nivolumab

Delhi HC allows Zydus to sell biosimilar of blockbuster anti-cancer drug Nivolumab

DoP may exempt 11 more drugs from public procurement rules

DoP may exempt 11 more drugs from public procurement rules

DoP calls for proposals to set up common facilities for medical device clusters

DoP calls for proposals to set up common facilities for medical device clusters

TN Information Commission raps petitioner for abusing RTI Act with excessive requests

TN Information Commission raps petitioner for abusing RTI Act with excessive requests

Granules India gets USFDA tentative nod for generic ADHD treatment tablets

Granules India gets USFDA tentative nod for generic ADHD treatment tablets

Polymatech begins domestic manufacturing of vein finder devices

Polymatech begins domestic manufacturing of vein finder devices